|
Financial Instruments
|
9 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2011
|
|||
| Financial Instruments [Abstract] | |||
| Financial Instruments |
The carrying amount of the Company's financial instruments, including cash and cash equivalents, accounts receivable and accounts payable, notes receivable, accrued expenses and other liabilities approximates fair value due to their relatively short maturity. Prior to February 9, 2010, the Company sold products in various global markets. As a result, the Company was exposed to changes in foreign currency exchange rates. The Company does not hold derivative financial instruments for speculative purposes. Foreign currency transaction gains and (losses) included in other income (expense), were $27 and $66 for the nine months ended December 31, 2011 and 2010, respectively. On December 31, 2011, the Company had no open foreign exchange contracts to sell Euros or any other foreign currencies. On December 31, 2011, the Company had 41,741 warrants outstanding with an exercise price of $30.00 expiring between June 2013 and September 2013. For the nine months ended December 31, 2011 and 2010, respectively, the Company recorded non-cash gains of $6 and $344 related to these warrants. The Company recorded a non-cash loss related to the warrants of $8 in the quarter ended December 31, 2011 and a non-cash gain of $3 in the quarter ended December 31, 2010.
|